Is Ozempic Only an Injection? Exploring Its Forms and Uses

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become a cornerstone of personalized weight loss therapy since its approval by the FDA. Many people assume semaglutide only comes as an injection, but the medication is now available in multiple delivery forms, each with distinct advantages and considerations for different patients.

Understanding Semaglutide: Injection vs. Oral Forms

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that regulates appetite, blood sugar, and metabolism. The injection form, administered once weekly under the skin, delivers the full dose directly into the bloodstream, allowing rapid absorption and consistent therapeutic levels. Oral semaglutide tablets, taken once daily, are absorbed through the stomach lining and require specific administration steps—taken on an empty stomach 30 minutes before food—to maximize bioavailability.

Clinical trials show both forms produce meaningful weight loss, though injection semaglutide typically achieves faster results due to its immediate absorption profile. Oral semaglutide offers convenience for needle-averse patients and allows for more frequent dose adjustments without additional injections. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, making weekly therapy accessible without insurance or membership fees.

How Injectable Semaglutide Differs From Oral Administration

Injectable semaglutide delivers medication directly beneath the skin once per week, bypassing the digestive system and ensuring consistent plasma levels for seven days. This weekly schedule simplifies adherence for many patients and allows healthcare providers to make meaningful dose increases every four weeks. The injection method also eliminates variability caused by food interactions, stomach acid, or absorption timing issues that can affect oral medications.

Oral semaglutide requires stricter timing and preparation—patients must take tablets on an empty stomach with a small amount of water and wait 30 minutes before eating or taking other medications. This complexity can lead to inadvertent dose reductions if administration guidelines are not followed precisely. However, patients who prefer daily medication routines or have difficulty with injections often find oral semaglutide more compatible with their lifestyle. PlexusDx compounded oral semaglutide is $289/mo month-to-month (or $249/mo on the 6-month plan), offering an alternative for those seeking tablet-based therapy.

Effectiveness and Weight Loss Outcomes With Each Form

Data from randomized controlled trials demonstrate that injectable semaglutide at its highest dose produces average weight loss of 15% of body weight over 68 weeks of treatment. Oral semaglutide achieves approximately 10-12% weight loss at comparable doses, reflecting differences in absorption and sustained plasma concentrations between delivery methods. Individual results vary based on genetics, baseline metabolic health, and adherence to the prescribed therapy protocol.

The Precision Peptide Genetic Test from PlexusDx analyzes variants in the GLP1R and GIPR genes, which influence how your body responds to semaglutide therapy. Patients with certain genetic profiles may experience stronger appetite suppression or faster metabolic benefits from either form. Understanding your genetic predispositions helps PlexusDx providers select the most effective semaglutide delivery method for your unique physiology, ensuring maximum weight loss potential from the start.

Choosing the Right Semaglutide Form for Your Lifestyle

The decision between injectable and oral semaglutide depends on personal preferences, treatment goals, and practical considerations. Injections suit patients seeking faster results, those who travel frequently and prefer weekly dosing, or individuals with gastrointestinal conditions that impair medication absorption. Oral tablets work well for patients with needle anxiety, those on complex medication schedules who can manage daily timing, or those preferring daily engagement with their treatment.

PlexusDx streamlines the selection process by offering both forms at transparent, flat monthly prices—$189 for compounded semaglutide injection and $289 for oral semaglutide—with no flat per-compound pricing increases. Your dose may need to go up as your body adapts, but your price won't. All medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality. HSA and FSA accounts are accepted, making either form accessible to patients seeking personalized weight loss therapy without insurance barriers.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I switch from semaglutide injections to oral tablets or vice versa?

Yes, patients can transition between injectable and oral semaglutide under medical supervision. Because oral semaglutide produces lower plasma concentrations than injections at equivalent doses, dose adjustments are typically necessary when switching delivery methods. PlexusDx providers guide this transition carefully to maintain consistent weight loss progress.

Which semaglutide form produces faster weight loss results?

Injectable semaglutide typically produces faster weight loss than oral tablets because it bypasses the digestive system and achieves higher and more stable blood levels immediately. Clinical trials show injectable semaglutide averages 15% body weight loss compared to 10-12% for oral formulations. However, both forms are effective, and individual genetics significantly influence response rates.

What does semaglutide cost at PlexusDx, and do prices increase with higher doses?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and oral semaglutide at $289/mo (or $249/mo on the 6-month plan), with flat pricing across all commitment tiers. Your dose may need to go up as your treatment progresses, but your price remains fixed—no dose-based increases. HSA and FSA accounts cover both forms, and no insurance or membership fee is required.

Are there side effects that differ between injectable and oral semaglutide?

Both forms produce similar side effects, primarily gastrointestinal symptoms like nausea, constipation, or mild vomiting, which typically resolve within 2-4 weeks as your body adapts. Oral semaglutide may cause additional heartburn due to daily administration timing, while injectable semaglutide side effects are concentrated in the first 24-48 hours after injection. Your PlexusDx provider monitors symptoms and can adjust your dose or delivery method accordingly.

How does the Precision Peptide Genetic Test help me choose between semaglutide forms?

The Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R and GIPR genes that directly influence your response to semaglutide. Patients with specific genetic profiles may achieve superior results with injections over oral tablets, or vice versa, helping PlexusDx personalize your therapy choice for maximum weight loss potential.

Related Reading

• Injection Ozempic
• Ozempic Uses
• Injection Sites For Ozempic
• Ozempic Injection Sites

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.